Angiotensin receptor blockers tied to less ventilation, vasopressors in men with COVID-19

Use of angiotensin receptor blockers was associated with less need for ventilation and vasopressors among men hospitalized with COVID-19, but not in women, according to research presented at the Society of Critical Care Medicine Congress.
Research to date has demonstrated that men have worse COVID-19 outcomes than women, with a similar number of cases and no difference in mortality between sexes, but more hospitalizations and ICU admissions in men, Genevieve Rocheleau, MSc, summer research student at the University of British Columbia Centre for Health Lung Innovation in Critical Care Medicine

Use of angiotensin receptor blockers was associated with less need for ventilation and vasopressors among men hospitalized with COVID-19, but not in women, according to research presented at the Society of Critical Care Medicine Congress.
Research to date has demonstrated that men have worse COVID-19 outcomes than women, with a similar number of cases and no difference in mortality between sexes, but more hospitalizations and ICU admissions in men, Genevieve Rocheleau, MSc, summer research student at the University of British Columbia Centre for Health Lung Innovation in Critical Care Medicine